Drug Trial Radar · NCT06747858
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Last checked: Nov 19, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
33
Planned (sponsor's estimate)
Start
Dec 12, 2024
Primary completion
Jun 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Arcturus Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to drug intolerance, poor response, or lack of access to modulators.
Conditions
- Cystic Fibrosis
- CFTR Gene Mutation
Interventions
ARCT-032Biological
CFTR mRNA formulated in lipid nanoparticles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, severity and dose relationship of adverse eventsTime frame: Cohorts 1-3: 16 weeks and Cohort 4: 24 weeks
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
University of Arizona
Tucson, Arizona · Recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas · Recruiting
Children's Hospital of Los Angeles
Los Angeles, California · Recruiting
Children's National Hospital
Washington D.C., District of Columbia · Not yet recruiting
Joe DiMaggio Children's Hospital
Hollywood, Florida · Recruiting
The Cystic Fibrosis Institute
Northfield, Illinois · Active not recruiting
Boston Children's Hospital
Boston, Massachusetts · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Cleveland Clinic Foundation
Cleveland, Ohio · Recruiting
Medical University of South Carolina
Charleston, South Carolina · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
UT Health San Antonio
San Antonio, Texas · Recruiting
Seattle Children's Hospital
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.